Zytiga 250 mg

ZYTIGA 250 MG tablets contain abiraterone acetate, a medication used in cancer treatment. This oral tablet is manufactured by Janssen Inc. in Canada and is available in a 120-tablet pack.

ZYTIGA 250 MG tablets are primarily used in the treatment of prostate cancer. Abiraterone acetate works by reducing androgen production, which can help slow the progression of certain types of cancer. This medication is often prescribed as part of a comprehensive treatment plan.

Common effects of ZYTIGA 250 MG tablets may include fatigue, joint pain, and swelling. Some users may also experience high blood pressure or changes in liver function. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

ZYTIGA 250 MG tablets should be handled with care and stored as directed. This medication may interact with other drugs, so it is important to inform your healthcare provider about all medications you are taking. Pregnant women should avoid handling the tablets due to potential risks.

ZYTIGA 250 MG tablets may interact with certain medications, including those metabolized by the liver. Alcohol and other substances that affect liver function should be avoided. Always consult a healthcare provider before starting or stopping any medication.